Bluetooth enabled point-of-care INR device validation for warfarin management.

Area of Science:

• Medical Devices
• Clinical Chemistry
• Pharmacology

Background:

• Effective warfarin management relies on accurate INR monitoring.
• Point-of-care (POC) INR testing with patient self-testing requires accuracy, data integrity, and timely communication.
• Validating POC devices for seamless INR data transfer to electronic medical records is crucial.

Purpose of the Study:

• To validate a Bluetooth-enabled POC INR device for prompt INR transfer to electronic medical records.
• To compare the accuracy of two POC INR devices (Vantus and CoaguChek) against a plasma INR reference.

Main Methods:

• A multicenter study compared two commercial POC INR devices (Vantus, CoaguChek) against a plasma INR reference.
• 151 warfarin-treated patients were enrolled across three Mayo Clinic sites.
• Appropriateness of dosing decisions was assessed for each device.

Main Results:

• Both Vantus and CoaguChek devices showed high concordance with plasma INR.
• 88.7% of Vantus values and 86.1% of CoaguChek values fell within 0.4 INR units of plasma INR.
• Appropriate dosing recommendations were similar between devices (Vantus 82.7%, CoaguChek 83.4%).

Conclusions:

• INR values from CoaguChek and Vantus devices strongly correlate with plasma INR.
• These POC devices exhibit no systemic bias when compared to plasma INR.
• The devices are suitable for accurate INR monitoring in warfarin management.